Results 81 to 90 of about 3,844,628 (256)

Sustained virologic response rates (95% confidence intervals) in participants with HCV GT1 infection who initiated direct-acting antiviral treatmenta.

open access: yes, 2019
Sustained virologic response rates (95% confidence intervals) in participants with HCV GT1 infection who initiated direct-acting antiviral treatmenta.
David Muschi (7300049)   +5 more
core   +1 more source

Importin 7 mediates the nuclear import of HIV‐1 integrase via a specific interacting interface

open access: yesFEBS Open Bio, EarlyView.
HIV‐1 integrase enables viral DNA integration into the host genome. By binding to the core domain of the host protein Importin 7 via its C‐terminal domain, the integrase is transported across the nuclear membrane into the nucleus, where integration of the viral genome into host DNA takes place. This translocation is a critical step for subsequent viral
Juana Bana   +5 more
wiley   +1 more source

Direct-acting antivirals for flaviviruses.

open access: yes, 2022
Direct-acting antivirals for flaviviruses.
Vinod RMT Balasubramaniam (12475307)   +3 more
core   +1 more source

Current and Future Direct-Acting Antivirals Against COVID-19 [PDF]

open access: yesFrontiers in Microbiology, 2020
The coronavirus disease of 2019 (COVID-19) has caused an unprecedented global crisis. The etiological agent is a new virus called the severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2). As of October, 2020 there have been 45.4 million confirmed cases with a mortality rate of 2.6% globally.
openaire   +3 more sources

Identification of (20R)‐protopanaxadiol from Panax ginseng as a novel anti‐SARS‐CoV‐2 compound

open access: yesFEBS Open Bio, EarlyView.
We established a noninfectious BAC‐based SARS‐CoV‐2 replicon that enables antiviral screening under BSL‐2 conditions. Using this platform, we screened 373 food‐derived compounds and identified (20R)‐protopanaxadiol from Panax ginseng as a novel inhibitor of SARS‐CoV‐2 RNA replication, highlighting the value of safe replicon systems for antiviral ...
Midori Takeda   +4 more
wiley   +1 more source

Successfully treatment of chronic hepatitis C with direct-acting antiviral agents: a single center experience

open access: yesThe Turkish Journal of Gastroenterology, 2019
INTRODUCTION: The aim of the present study was to evaluate the efficacy and tolerability of ledipasvir/sofosbuvir (LDV/SOF) with or without ribavirin (RBV), and Ombitasvir- ritonavir/Paritaprevir/Dasabuvir (PrOD) with or without RBV in the treatment of ...
Aysun Kartal   +7 more
doaj   +1 more source

Changes in health-related quality of life scores from the baseline to the week 4 of treatment with direct-acting antiviral agents.

open access: yes, 2018
Changes in health-related quality of life scores from the baseline to the week 4 of treatment with direct-acting antiviral agents.
Regina Juanbeltz (5832653)   +5 more
core   +1 more source

Protocol for quantifying miRNA trafficking across the endosomal membrane

open access: yesFEBS Open Bio, EarlyView.
An in vitro protocol measures miRNA uptake into endosomes isolated from mammalian cell extracts, which are free of subcellular contaminants. Performed at 37 °C in the presence of ATP, it ensures the import of single‐stranded miRNA into the endosomal lumen.
Syamantak Ghosh   +2 more
wiley   +1 more source

Ombitasvir, paritaprevir, and ritonavir with peginterferon-α2a plus ribavirin in treatment-experienced patients with chronic hepatitis C virus genotype 1 infection

open access: yesHepatic Medicine: Evidence and Research, 2019
David Bernstein,1 Rakesh Tripathi,2 Daniel E Cohen2 1Zucker School of Medicine, Hofstra University, Hempstead, New York, NY, USA; 2AbbVie Inc., North Chicago, IL, USA Background: This international, phase 2, open-label, multicenter study (ClinicalTrials ...
Bernstein D, Tripathi R, Cohen DE
doaj  

Changes in health-related quality of life scores from the baseline to the week 12 post-treatment with direct-acting antiviral agents.

open access: yes, 2018
Changes in health-related quality of life scores from the baseline to the week 12 post-treatment with direct-acting antiviral agents.
Regina Juanbeltz (5832653)   +5 more
core   +1 more source

Home - About - Disclaimer - Privacy